Multi-center phase 3 trial of chlorhexidine gluconate chip for the use in subjects with peri-implantitis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Chlorhexidine (Primary)
- Indications Peri-implantitis
- Focus Registrational; Therapeutic Use
- Sponsors Dexcel-Pharma
- 01 Feb 2018 Planned End Date changed from 1 Jun 2018 to 1 Dec 2018.
- 01 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Aug 2018.
- 01 Feb 2018 Status changed from recruiting to active, no longer recruiting.